February 8, 2021
At the Regulatory Submissions, Information, and Document Management Forum, content and regulatory information management and submissions. Daily plenary sessions providing regulatory intelligence updates by health authority representatives from FDA, Health Canada, and other regions of interest.
February 23, 2021
World Drug Safety Congress US Webinar. Watch live or on demand. Topic overview: Decreasing budgets and increasing case volumes require a more efficient model in drug safety. Is automation part of that model? A recent survey conducted by a global consultancy found that workflow automation is rated as the most critical buying factor when large biopharmas are choosing safety software. Despite the many bold claims around automation in the industry, few have any real-world proof points to support them.
March 10, 2021
World Drug Safety Congress EU Webinar. Watch the live webinar or on demand.
March 15 – 19, 2021
20 min. Webinar engaging with DIA Europe audience members. DIA Europe 2021 is unique in presenting the entire healthcare value chain ranging from policy and regulations to R&D, marketing and access. Program sessions include topics from nine core thought leadership streams focused on specific therapy areas, including: Beating Cancer, Crisis Preparedness and Response, Smart Health and many more.
March 22, 2021
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, by medical affairs professionals, regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals.
April 20-22, 2021Comprised of IDMP/SPOR task force members and leading experts in the pharmaceutical field, the Global Pharmaceutical Regulatory Affairs Summit 2021 virtual agenda covers a wide spectrum of the global pharmaceutical regulatory affairs industry. As a virtual attendee, you’ll still be able to interact directly with every speaker to ask questions and uncover solutions to your current challenges.
May 11, 2021
Small exclusive Safety executive leaders who face strategic challenges are brought together in this rountable 60-minute webinar discussions. Enables participants to share ideas and lessons learned. Facilitated by ArisGlobal thought leaders, these sessions provide a valuable dialogue over challenges and topical issues. Each roundtable discussion group has a mix of CxO, VP and Director-level individuals which ensures each delegate is given ample opportunity to raise questions and contribute from a strategic perspective.
May 19, 2021
In “Transitioning from Medical Information to Medical Intelligence”, Sandeep Mahagaonkar, Sr. Director, Medical Affairs and Quality Product Management at ArisGlobal, shares his knowledge and expertise on the trends shaping the MI automation space and how medical information teams can be better equipped with new and emerging technologies in business process automation.
May 20, 2021 at 11:00am EST
Regulatory Departments at EU life science companies are finally gearing up for IDMP implementation after years of policy development. IDMP can be considered a framework for investing in the processes and technology to not only achieve compliance, but to also address the end-to-end processes throughout the regulatory lifecycle. Thinking about IDMP from the beginning of your team’s process will avoid costly delays and achieve full compliance that is also scalable and ready for future growth. IDMP compliance is a timely springboard to address your larger regulatory strategy. We’ll also discuss what investments are needed as we look forward to the future of automation and AI improvements that help simplify compliance processes and bring a new level of innovation to geographically diverse regulatory teams.Please join us on May 20.
Decentralized Clinical Trials – Collaboration Urgency Grows
May 25, 2021 at 11:00am EST
When Covid-19 hit, the concept of decentralized trials suddenly switched from nice idea to necessity. The urgency of the pandemic pushed decentralization to center stage.
During this panel discussion with a case study and Q&A, we will consider:
- What percentage of current trials are decentralized?
- How has decentralization changed the nature of collaboration among clinical research partners?
- What are your primary concerns about putting decentralized trials into operation?
- How will regulatory authorities respond if more studies add decentralized features?
June 28, 2021
DIA’s virtual Global Annual Meeting gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries to advance innovation in healthcare product development and lifecycle management globally.
July 20, 2021
Small exclusive Clinical executive leaders who face strategic challenges are brought together in this roundtable 60-minute webinar discussions. Enables participants to share ideas and lessons learned. Facilitated by ArisGlobal thought leaders, these sessions provide a valuable dialogue over challenges and topical issues. Each roundtable discussion group has a mix of CxO, VP and Director-level individuals which ensures each delegate is given ample opportunity to raise questions and contribute from a strategic perspective.
| Virtual Event